NSEShareholders meeting4d ago · 27 Aug 2026, 02:26 pm
Shareholders meeting
Tatva Chintan Pharma Chem Limited · TATVA
✦ AI Summaryshareholders_meeting
Tatva Chintan Pharma Chem Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 25, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Tatva Chintan Pharma Chem Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 25, 2026
Attachments (1)
📄pdf
Download →
TATVA_27082026142556_NFY26.pdf
View document text
Date:27August 2026 Ref.No.:TCPCL/SEC/2026-27/00038
TheGeneralManager, TheManager,
Corporaterelationshipdepartment, Listingdepartment,
BSELimited NationalStockExchangeofIndiaLimited
PhirozeJeejeebhoyTowers, ExchangePlaza,C-1,Block-G,
DalalStreet,Fort, Bandra-KurlaComplex,Bandra(E),
Mumbai-400001 Mumbai-400051
ScripCode:543321 ScripSymbol:TATVA
Subject: Notice of the 30th Annual General Meeting (“AGM”) of the Company as
requiredunderRegulation30oftheSEBI(ListingObligationsandDisclosure
Requirements)Regulations,2015(“SEBIListingRegulations”)
DearSir/Madam,
Pursuant to Regulation 30 of the SEBI Listing Regulations, please find enclosed herewith
Notice alongwithExplanatoryStatement ofthe 30th AGMof the Members oftheCompany
scheduled to be held on Friday, 25 September 2026 at 04:00 p.m. (IST) through Video
Conferencing ("VC") / Other Audio Visual Means ("OAVM"). The said Notice forms
partoftheAnnualReport2025-26.
The Notice of the 30th AGM of the Company is also available on the website of the
Companyatwww.tatvachintan.com.
Kindlytaketheaboveinformationonrecord.
Thankingyou,
Yoursfaithfully,
ForTatvaChintanPharmaChemLimited
IshwarNayi
CompanySecretaryandComplianceOfficer
M.No.:A37444
Encl.:AsAbove
Notice
NOTICE IS HEREBY GIVEN THAT THE THIRTIETH (30TH) ANNUAL including from Central Government, if any, as may be required,
GENERAL MEETING (“AGM”) OF THE MEMBERS OF TATVA CHINTAN Mr. Chintan Nitinkumar Shah (DIN: 00183618) be and is
PHARMA CHEM LIMITED (“THE COMPANY”) WILL BE HELD ON hereby re-appointed as Managing Director of the Company
FRIDAY, 25 SEPTEMBER 2026 AT 04:00 P.M. (IST) THROUGH VIDEO to act as such, for a further period of three (3) years from
CONFERENCING (“VC”) / OTHER AUDIO VISUAL MEANS (“OAVM”) 01 February 2027 to 31 January 2030 (both days inclusive),
TO TRANSACT THE FOLLOWING BUSINESSES: liable to retire by rotation, with substantial powers of
management of the affairs of the Company as of a Managing
ORDINARY BUSINESS: Director, as defined under Section 2(54) of the said Act, but
subject to the superintendence, direction and control of
1. T o receive, consider and adopt the Audited Standalone
the Board of Directors of the Company; on the terms and
Financial Statements of the Company for the financial year
conditions of appointment and remuneration as set out in the
ended 31 March 2026, together with the Reports of the Board
explanatory statement annexed to the Notice convening this
of Directors and the Auditors thereon.
Meeting, with a liberty and power to the Board of Directors
of the Company (including its Committee constituted for the
2. T o receive, consider and adopt the Audited Consolidated
purpose) to alter and vary the terms and conditions of the
Financial Statements of the Company for the financial year
said re-appointment as agreed by and between the Board of
ended 31 March 2026, together with the Report of the
Directors and Mr. Chintan Nitinkumar Shah.
Auditors thereon.
R ESOLVED FURTHER THAT notwithstanding anything
3. T o declare dividend on equity shares for the financial year
contained to the contrary in the Companies Act, 2013,
ended 31 March 2026.
wherein any financial year the Company has no profits or
inadequate profit, Mr. Chintan Nitinkumar Shah shall be paid
4. To appoint a Director in place of Mr. Shekhar Rasiklal Somani
remuneration, perquisites and / or allowances as stated in the
(DIN: 00183665) who retires by rotation and being eligible,
explanatory statement as minimum remuneration.
offers himself for re-appointment.
R ESOLVED FURTHER THAT in the event of any statutory
SPECIAL BUSINESS:
amendment or modification by the Central Government to
5. R e-appointment of Mr. Chintan Nitinkumar Shah (DIN: Schedule V of the Companies Act, 2013, the Board of Directors
00183618), as the Managing Director of the Company for a be and are hereby authorized to vary and alter the terms of
period of three (3) years with effect from 01 February 2027 appointment including salary, allowances, perquisites etc.
and fixation of remuneration. payable to Mr. Chintan Nitinkumar Shah within such prescribed
limit or ceiling and as agreed by and between the Company and
To consider and, if thought fit, to pass with or Mr. Chintan Nitinkumar Shah without any further reference by
without modification(s), the following Resolution as a the Company in General Meeting.
Special Resolution:
R ESOLVED FURTHER THAT pursuant to the prescribed
“RESOLVED THAT pursuant to the provisions of Sections 152, provisions of Regulation 17(6)(e) of the SEBI (Listing
196, 197, 198, 203 read with Schedule V and other applicable Obligations and Disclosure Requirements) Regulations, 2015
provisions, if any, of the Companies Act, 2013 (“the Act”) (“SEBI Listing Regulations”) and other applicable regulations,
and the Rules made thereunder [including any statutory and subject to the maximum remuneration approved by
modification(s) or re-enactment(s) thereof for the time being the members, approval of the Members of the Company
in force] and as per relevant provisions of the Securities and be and is hereby accorded for payment of remuneration to
Exchange Board of India (Listing Obligations and Disclosure Mr. Chintan Nitinkumar Shah, Managing Director, Promoter
Requirements) Regulations, 2015 (“SEBI Listing Regulations”), of the Company as per the requirements of Regulation 17(6)
as amended from time to time (including any amendments (e) of the SEBI Listing Regulations.
thereto or re-enactment thereof, for the time being in force)
(hereinafter collectively referred to as the “Applicable Laws”) R ESOLVED FURTHER THAT the Board of Directors of the
and the Articles of Association of the Company and as approved Company (including its Committee thereof) be and is hereby
and recommended by the Nomination and Remuneration authorised to do all such acts, deeds, matters and things as
Committee and by the Board of Directors of the Company and may be necessary, expedient and desirable for the purpose of
subject to such other approvals, permissions and sanctions giving effect to this resolution.”
Annual Report 2025-26 1
6. R e-appointment of Mr. Ajaykumar Mansukhlal Patel (DIN: R ESOLVED FURTHER THAT pursuant to the prescribed
00183745), as the Whole-time Director of the Company for provisions of Regulation 17(6)(e) of the SEBI (Listing Obligations
a period of three (3) years with effect from 01 February 2027 and Disclosure Requirements) Regulations, 2015 (“SEBI Listing
and fixation of remuneration. Regulations”) and other applicable regulations, and subject
to the maximum remuneration approved by the members,
To consider and, if thought fit, to pass with or approval of the Members of the Company be and is hereby
without modification(s), the following Resolution as a accorded for payment of remuneration to Mr. Ajaykumar
Special Resolution: Mansukhlal Patel, Whole-time Director, Promoter of the
Company as per the requirements of Regulation 17(6)(e) of
“RESOLVED THAT pursuant to the provisions of Sections 152, the SEBI Listing Regulations.
196, 197, 198, 203 read with Schedule V and other applicable
provisions, if any, of the Companies Act, 2013 (“the Act”) R ESOLVED FURTHER THAT the Board of Directors of the
and the Rules made thereunder [including any statutory Company (including its Committee thereof) be and is hereby
modification(s) or re-enactment(s) thereof for the time being authorised to do all such acts, deeds, matters and things as
in force] and as per relevant provisions of the Securities and may be necessary, expedient and desirable for the purpose of
Exchange Board of India (Listing Obligations and Disclosure giving effect to this resolution.”
Requirements) Regulations, 2015 (“SEBI Listing Regulations”),
as amended from time to time (including any amendments 7. R e-appointment of Mr. Shekhar Rasiklal Somani (DIN:
thereto or re-enactment thereof, for the time being in force) 00183665), as the Whole-time Director of the Company for
(hereinafter collectively referred to as th
[Showing first 8,000 characters — download PDF for full document]